Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Seminars in Hematology|March 31, 2019
Can we predict responsiveness to hypomethylating agents in AML?Julia Stomper, Michael LübbertLeukemia|May 7, 2021
Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapiesJulia Stomper, John Charles Rotondo, Gabriele Greve, et al.Cell Reports|April 3, 2025
Sex differences in DNMT3A-mutant clonal hematopoiesis and the effects of estrogenJulia Stomper, Abhishek Niroula, Roger Belizaire, et al.World Journal of Urology|March 21, 2013
Landscape of chromosome number changes in prostate cancer progressionMartin Braun, Julia Stomper, Robert Kirsten, et al.The Journal of Molecular Diagnostics : JMD|May 31, 2012
Improved method of detecting the ERG gene rearrangement in prostate cancer using combined dual-color chromogenic and silver in situ hybridizationMartin Braun, Julia Stomper, Diana Boehm, et al.Haematologica|September 2, 2018
Fetal hemoglobin induction during decitabine treatment of elderly patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: a potential dynamic biomarker of outcomeJulia Stomper, Gabriele Ihorst, Stefan Suciu, et al.Clinical Epigenetics|April 13, 2021
Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patientsJulia Stomper, Ruth Meier, Tobias Ma, et al.Cancer Research|November 18, 2020
Decitabine Induces Gene Derepression on Monosomic Chromosomes: <i>In Vitro</i> and <i>In Vivo</i> Effects in Adverse-Risk Cytogenetics AMLGabriele Greve, Julia Schüler, Björn A Grüning, et al.Blood Cancer Journal|August 22, 2022
The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperationRuth Meier, Gabriele Greve, Dennis Zimmer, et al.European Journal of Haematology|June 3, 2025
Sensitization of Non-M3 Acute Myeloid Leukemia Blasts to All-Trans Retinoic Acid by the LSD1 Inhibitor Tranylcypromine: TRANSATRA Phase I StudyMichael Kruszewski, Claudia Schmoor, Tobias Berg, et al.Pageof 1